Transitional Cell Carcinoma of the Kidneys 2022: Pearls and Pitfalls - Part 2

Transitional Cell Carcinoma of the Kidneys 2022: Pearls and Pitfalls - Part 3Подробнее

CT of the Ureter and Bladder: Pearls and Pitfalls Part 2Подробнее

Transitional Cell Carcinoma of the Kidneys 2022: Pearls and Pitfalls - Part 1Подробнее

Histopathology Kidney--Transitional cell carcinomaПодробнее

Critical Updates in Kidney, Prostate, and Bladder Cancer from ASCO 2023 with Dr. Toni ChoueiriПодробнее

CT Evaluation of Primary Adrenocortical Carcinoma Part 2Подробнее

Bloody Mess: Evaluation of Hematuria in the ER Patient Part 2Подробнее

MDCT/CTA Evaluation of the Suspected Renal Mass: Key Differential Diagnosis Points - Part 2Подробнее

MDCT/CTA Evaluation of the Suspected Renal Mass: Key Differential Clues – Part 2Подробнее

Upper Tract Urothelial Carcinomas | Part II: Treatment OptionsПодробнее

Clinical trials in kidney cancer to look out forПодробнее

CT of Calyceal Abnormalities in the Kidney: Pearls and PitfallsПодробнее

Changing kidney cancer treatment landscapeПодробнее

Treating Upper Tract Urothelial Carcinoma (UTUC)Подробнее

Combination therapy for patients with kidney cancerПодробнее

Kidney Cancer Highlights from ESMO 2022Подробнее

Transitional Cell Carcinoma: Challenges in DetectionПодробнее

ASCO® GU Data Updates in Frontline Kidney Cancer: Was Anything Practice Changing?Подробнее

My Cancer JourneyПодробнее